Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells - PubMed (original) (raw)

. 1987 May 1;138(9):2923-8.

PMID: 3033079

Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells

J Buck et al. J Immunol. 1987.

Abstract

Autocrine growth factor for Epstein-Barr virus-transformed human B cells (aBGF), a protein that is constitutively produced by the human EBV-transformed B cell line 5/2, has been purified from serum-free conditioned medium. The purification involved sequential ammonium sulfate precipitation, ion exchange chromatography, gel filtration, and reversed-phase high performance liquid chromatography. The purified protein has a m.w. of 16,000 in NaDodSO4/polyacrylamide gel electrophoresis and an isoelectric point between 7.0 and 8.0. The relative molecular mass 16,000 form exists in equilibrium with dimeric and tetrameric forms. aBGF supports the growth of EBV-transformed B cells, which have been deprived of their own conditioned medium. The purified aBGF is fully effective at 0.5 ng/ml and has no interleukin 1 activity in the lymphocyte activation factor assay. Because several randomly selected lines of EBV-transformed cells and one EBV-negative lymphoma cell line both produce aBGF activity and show growth dependency on aBGF and because stimulation of normal B cells with anti-immunoglobulin M is increased by aBGF, we propose that aBGF has general significance for growth control of human B cells.

PubMed Disclaimer

Cited by

A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes.
Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, Birkenbach M. Devergne O, et al. J Virol. 1996 Feb;70(2):1143-53. doi: 10.1128/JVI.70.2.1143-1153.1996. J Virol. 1996. PMID: 8551575 Free PMC article.
Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.
Randhawa PS, Zeevi A, Alvares C, Gollin S, Agostini R, Yunis E, Saidman S, Contis L, Demetris AJ, Nalesnik MA. Randhawa PS, et al. In Vitro Cell Dev Biol Anim. 1994 Jun;30A(6):400-6. doi: 10.1007/BF02634361. In Vitro Cell Dev Biol Anim. 1994. PMID: 8087305
Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.
Sung SS, Jung LK, Walters JA, Chen W, Wang CY, Fu SM. Sung SS, et al. J Exp Med. 1988 Nov 1;168(5):1539-51. doi: 10.1084/jem.168.5.1539. J Exp Med. 1988. PMID: 3263462 Free PMC article.
The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
Callard RE, Lau YL, Shields JG, Smith SH, Cairns J, Flores-Romo L, Gordon J. Callard RE, et al. Immunology. 1988 Nov;65(3):379-84. Immunology. 1988. PMID: 3145248 Free PMC article.
Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines.
Birkenbach M, Liebowitz D, Wang F, Sample J, Kieff E. Birkenbach M, et al. J Virol. 1989 Sep;63(9):4079-84. doi: 10.1128/JVI.63.9.4079-4084.1989. J Virol. 1989. PMID: 2548016 Free PMC article.

Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells - PubMed (original) (raw)